Stem Cell Ophthalmology Treatment Study II (NCT03011541)

🧪 Interventions in This Study

• Arm 1 (PROCEDURE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (4 Sites)

• MD Stem Cells — Westport, Connecticut
• MD Stem Cells — Coral Springs, Florida
• MD Stem Cells Kobinia Med — Vienna, Austria
• The Saudi-German Hospital — Dubai, United Arab Emirates

📞 Contact the Study Coordinator

Phone: (203) 423-9494

Email: stevenlevy@mdstemcells.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Retinal Disease

• Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections — San Antonio, Texas
• COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease — Madison, Wisconsin
• Data Gathering for A10900 — Anaheim, California
• Optimize Pediatric OCT Imaging — Durham, North Carolina
• Cell Collection to Study Eye Diseases — Bethesda, Maryland

Explore by condition: All Retinal Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.